Last reviewed · How we verify
ProAlgaZyme
At a glance
| Generic name | ProAlgaZyme |
|---|---|
| Sponsor | Health Enhancement Products, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- The Effects of ProAlgaZyme on HDL Cholesterol in Individuals With Metabolic Syndrome (NA)
- ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency (NA)
- ProAlgaZyme Novel Algae Infusion: Applications in Metabolic Syndrome (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ProAlgaZyme CI brief — competitive landscape report
- ProAlgaZyme updates RSS · CI watch RSS
- Health Enhancement Products, Inc. portfolio CI